Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Communications

• Publication date

  2014-06-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/ncomms5280PMID 24969588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.

  2014cited by this paper
• Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection.

  2014cited by this paper
• Progress in microRNA delivery.

  2013cited by this paper
• Selective ablation of tumor‐associated macrophages suppresses metastasis and angiogenesis

  2013cited by this paper
• Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation

  2013cited by this paper
• Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment.

  2013cited by this paper
• Polymer nanocompartments in broad-spectrum medical applications.

  2013cited by this paper
• Current trends in the use of liposomes for tumor targeting.

  2013cited by this paper
• The tumor microenvironment: a target for combination therapy of breast cancer.

  2013cited by this paper
• Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice

  2013cited by this paper
• CSF-1R inhibition alters macrophage polarization and blocks glioma progression

  2013cited by this paper
• Effects of legumain as a potential prognostic factor on gastric cancers

  2013cited by this paper
• Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting

  2013cited by this paper
• Functional imaging of legumain in cancer using a new quenched activity-based probe.

  2013cited by this paper
• Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.

  2012cited by this paper
• Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.

  2012cited by this paper
• Cell-penetrating peptides: breaking through to the other side.

  2012cited by this paper
• Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

  2011cited by this paper
• The Legumain Protease‐Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.

  2011cited by this paper
• Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration.

  2011cited by this paper
• Asparagine endopeptidase is required for normal kidney physiology and homeostasis

  2011cited by this paper
• Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity.

  2011cited by this paper
• Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications.

  2011cited by this paper
• Doped Mott insulators: Breaking through to the other side

  2010cited by this paper
• A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain.

  2009cited by this paper
• Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).

  2009cited by this paper
• A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

  2008cited by this paper
• Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

  2008cited by this paper
• Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens.

  2008cited by this paper
• Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

  2008cited by this paper
• Cell-penetrating and cell-targeting peptides in drug delivery.

  2008cited by this paper
• Editorial

  2008cited by this paper
• Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.

  2008cited by this paper
• Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.

  2006cited by this paper
• Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Targeting tumor-associated macrophages as a novel strategy against breast cancer.

  2006cited by this paper
• Cationic TAT peptide transduction domain enters cells by macropinocytosis.

  2005cited by this paper
• Supramolecular drug-delivery systems based on polymeric core-shell architectures.

  2004cited by this paper
• Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.

  2004cited by this paper
• Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

  2003cited by this paper
• Inhibition of Mammalian Legumain by Michael Acceptors and AzaAsn-Halomethylketones

  2002cited by this paper
• Breaking Through to the Other Side

  1994cited by this paper

• Split-Deliver-Click: Tumor-Specific Protein Degradation via "AND" Logic-Gated In-Cell Bioorthogonal Clicking of PROTACs.

  2026cites this paper
• Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy.

  2026cites this paper
• Long–term kinetic profiling of legumain–activated fluorescent probes and identification of a legumain substrate for cleavable linker design

  2026cites this paper
• Enzyme-Responsive Polymeric Materials with Anticancer and Antibacterial Activities.

  2025cites this paper
• Biomimetic drug delivery for anticancer: Focusing on the relationship between drugs and biomimetic carriers

  2025cites this paper
• Synthesis and Evaluation of Radiogallium-Labeled Peptide Probes for In Vivo Imaging of Legumain Activity

  2025cites this paper
• Organelle-oriented nanomedicines in tumor therapy: Targeting, escaping, or collaborating?

  2025cites this paper
• A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice

  2025cites this paper
• Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications

  2025cites this paper
• "Actual" peptide properties required for nanoparticle development in precision cancer therapeutic delivery.

  2025cites this paper
• Disruption and nebulization of lipid vesicles using surface acoustic waves for direct mass spectrometry.

  2025cites this paper
• Recent Advances in Peptide Linkers of Antibody-Drug Conjugates.

  2025cites this paper
• A Highly Tumor Permeating DNA Nanoplatform for Efficient Remodeling of Immunosuppressive Tumor Microenvironments.

  2024cites this paper
• Legumain-deficient macrophages regulate inflammation and lipid metabolism in adipose tissues to protect against diet-induced obesity.

  2024cites this paper
• Lysosome-targeting and legumain-triggered 68Ga-labeled probe for enhanced tumor PET imaging.

  2024cites this paper
• Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

  2023cites this paper
• Single-atom nanozymes based nanobee vehicle for autophagy inhibition-enhanced synergistic cancer therapy

  2023cites this paper
• Tumor-Targeted Fluorescent/Photoacoustic Imaging of Legumain Activity In Vivo.

  2023cites this paper
• Nanomedicine in cancer therapy

  2023cites this paper
• Hyperbranched Polymer-Based Vaccines for Cancer Immunotherapy.

  2023cites this paper
• Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery.

  2023cites this paper
• Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multi-drug Resistance.

  2023cites this paper
• Biological Properties of Arginine-rich Peptides and their Application in Cargo Delivery to Cancer.

  2023cites this paper
• Targeted delivery of pexidartinib to tumor-associated macrophages via legumain-sensitive dual-coating nanoparticles for cancer immunotherapy.

  2023cites this paper
• In situ MUC1-specific CAR engineering of tumor-supportive macrophages stimulates tumoricidal immunity against pancreatic adenocarcinoma

  2023cites this paper
• Role of LGMN in tumor development and its progression and connection with the tumor microenvironment

  2023cites this paper
• Combined Legumain- and Integrin- Targeted Nanobubbles for Molecular Ultrasound Imaging of Breast Cancer.

  2022cites this paper
• Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.

  2022cites this paper
• Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture

  2022cites this paper
• Self-oriented central-tumor delivery of legumain-cleavable vehicles governed by circulating monocyte/macrophage for precise tumor enrichment and immune activation

  2022cites this paper
• A decade's worth of impact: Dox loaded liposomes in anticancer activity

  2022cites this paper
• Insights on aortic aneurysm and dissection: Role of the extracellular environment in vascular homeostasis.

  2022cites this paper
• Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.

  2022cites this paper
• Bioinspired Lipoproteins of Furoxans–Oxaliplatin Remodel Physical Barriers in Tumor to Potentiate T‐Cell Infiltration

  2022cites this paper
• Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

  2022cites this paper
• Role of Nanoparticles in Cancer Therapy

  2022cites this paper
• Legumain/pH dual-responsive lytic peptide–paclitaxel conjugate for synergistic cancer therapy

  2022influential citation
• Development of a Promising 18F-Radiotracer for PET Imaging Legumain Activity In Vivo

  2022cites this paper
• Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.

  2022influential citation
• Legumain-mediated self-assembly of a 131I-labelled agent for targeted radiotherapy of tumors.

  2022cites this paper
• Photolytic Removal of Red Blood Cell Membranes Camouflaged on Nanoparticles for Enhanced Cellular Uptake and Combined Chemo-Photodynamic Inhibition of Cancer Cells.

  2022cites this paper
• DT-Diaphorase Triggered Theranostic Nanoparticles Induce the Self-burst of Reactive Oxygen Species for Tumor Diagnosis and Treatment.

  2021cites this paper
• Cell-penetrating peptides in cancer targeting

  2021cites this paper
• Design of Smart Size-, Surface-, and Shape-Switching Nanoparticles to Improve Therapeutic Efficacy.

  2021cites this paper
• Spatially targeting of tumor-associated macrophages and cancer cells for suppression of spontaneously metastatic tumor

  2021cites this paper
• Cell-penetrating peptides improve pharmacokinetics and pharmacodynamics of anticancer drugs

  2021cites this paper
• Synthesis, Characterization and Evaluation of Peptide Nanostructures for Biomedical Applications

  2021cites this paper
• Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA.

  2021cites this paper
• Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?

  2021cites this paper
• Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

  2021cites this paper
• Histone demethylase KDM6B inhibits breast cancer metastasis by regulating Wnt/β‐catenin signaling

  2021cites this paper
• Histone deacetylase 9 deficiency exaggerates uterine M2 macrophage polarization

  2021cites this paper
• Tumor progress intercept by intervening in Caveolin-1 related intercellular communication via ROS-sensitive c-Myc targeting therapy.

  2021cites this paper
• Remodeling tumor microenvironment with nanomedicines.

  2021cites this paper
• Nanomedicine-based strategies to target and modulate the tumor microenvironment.

  2021cites this paper
• Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B

  2021cites this paper
• Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition

  2021cites this paper
• Biopolymer-based materials in nanomedicine: Synthesis and characterization

  2021cites this paper
• Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages

  2021cites this paper
• Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms

  2021cites this paper
• The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy

  2021cites this paper
• Size-Adjustable Nano-Drug Delivery Systems for Enhanced Tumor Retention and Penetration

  2021cites this paper
• An endogenous stimulus detonated nanocluster-bomb for contrast-enhanced cancer imaging and combination therapy

  2021cites this paper
• Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade

  2021cites this paper
• Esomeprazole inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis

  2020cites this paper
• Interface Engineering in Multiphase Systems toward Synthetic Cells and Organelles: From Soft Matter Fundamentals to Biomedical Applications

  2020cites this paper
• 3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution

  2020cites this paper
• Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics.

  2020cites this paper
• Tumor-permeated bioinspired theranostic nanovehicle remodels tumor immunosuppression for cancer therapy.

  2020cites this paper
• Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy.

  2020cites this paper
• Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment

  2020cites this paper
• Cell Penetrating Peptides, Novel Vectors for Gene Therapy

  2020cites this paper
• Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.

  2020cites this paper
• Single-dose in situ storage for intensifying anticancer efficacy via combinatorial strategy.

  2020cites this paper
• The world of cell penetrating: the future of medical applications.

  2020cites this paper
• Biomedical nanoparticle design: What we can learn from viruses

  2020influential citation
• Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics

  2020cites this paper
• Nanotechnology enabled metal-ion-based disease diagnostics.

  2020cites this paper
• Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy.

  2020cites this paper
• Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy

  2020cites this paper
• Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment

  2019cites this paper
• Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

  2019cites this paper
• Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives

  2019cites this paper
• Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-&bgr;1 Signaling

  2019cites this paper
• Tumor‐specific macrophage targeting through recognition of retinoid X receptor beta

  2019cites this paper
• A novel strategy based on a ligand-switchable nanoparticle delivery system for deep tumor penetration

  2019cites this paper
• A protease‐responsive fluorescent probe for sensitive imaging of legumain activity in living tumor cells

  2019cites this paper
• Application of nanotechnology to target and exploit tumour associated proteases.

  2019cites this paper
• Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages

  2019cites this paper
• Asparaginyl endopeptidase induces endothelial permeability and tumor metastasis via downregulating zonula occludens protein ZO-1.

  2019cites this paper
• Active Nano-targeting of Macrophages.

  2019cites this paper
• Polymers for cytosolic protein delivery.

  2019cites this paper
• Prodrugs as drug delivery system in oncology

  2019cites this paper
• The current role of cell-penetrating peptides ( CPPs ) in cancer therapy

  2019cites this paper
• Construction of Nucleus-Targeting Iridium Nanocrystals for Photonic Hyperthermia-Synergized Cancer Radiotherapy.

  2019cites this paper
• Reactive Oxygen Species–Activatable Liposomes Regulating Hypoxic Tumor Microenvironment for Synergistic Photo/Chemodynamic Therapies

  2019cites this paper
• Tumor microenvironment responsive drug delivery systems

  2019cites this paper
• Ultra‐pH‐Sensitive Biopolymer Micelles Based on Nuclear Base Pairs for Specific Tumor‐Targeted Drug Delivery

  2019cites this paper
• Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis

  2019influential citation
• DESIGN, SYNTHESIS, AND STUDY OF ZINC-RESPONSIVE LIPID SWITCHES FOR TRIGGERED RELEASE OF LIPOSOMAL CONTENT

  2019cites this paper